Andreas Moritz

677 total citations
15 papers, 520 citations indexed

About

Andreas Moritz is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Andreas Moritz has authored 15 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Andreas Moritz's work include Influenza Virus Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and CAR-T cell therapy research (3 papers). Andreas Moritz is often cited by papers focused on Influenza Virus Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and CAR-T cell therapy research (3 papers). Andreas Moritz collaborates with scholars based in Austria, United States and Switzerland. Andreas Moritz's co-authors include Wolfgang R. Sperr, Kawe Goharkhay, Ulrich Schoop, J. Wernisch, Ming Qi Deng, Oral A. Evanson, Douglas J. Weiss, Mitchell S. Abrahamsen, E. Liehl and P. Reeve and has published in prestigious journals such as Scientific Reports, The Journal of Infectious Diseases and Infection and Immunity.

In The Last Decade

Andreas Moritz

15 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Moritz Austria 9 283 189 159 131 71 15 520
Ruchele Dias Nogueira Brazil 12 85 0.3× 85 0.4× 58 0.4× 184 1.4× 48 0.7× 38 412
Clay A. Henry United States 7 73 0.3× 181 1.0× 24 0.2× 179 1.4× 19 0.3× 12 362
Mathias Folwaczny Germany 7 48 0.2× 162 0.9× 47 0.3× 145 1.1× 105 1.5× 8 412
Claudia Ota‐Tsuzuki Brazil 11 29 0.1× 188 1.0× 66 0.4× 233 1.8× 22 0.3× 15 482
Ruoqiong Chen United States 12 40 0.1× 214 1.1× 41 0.3× 310 2.4× 24 0.3× 16 577
Preethi Balan Singapore 9 58 0.2× 36 0.2× 35 0.2× 211 1.6× 13 0.2× 28 415
V. T. Beena India 12 55 0.2× 105 0.6× 39 0.2× 116 0.9× 13 0.2× 37 429
C. George United States 8 112 0.4× 34 0.2× 29 0.2× 77 0.6× 10 0.1× 15 753
Kåre Tolo Norway 13 36 0.1× 51 0.3× 33 0.2× 359 2.7× 86 1.2× 24 589
R. Dei Italy 13 65 0.2× 26 0.1× 282 1.8× 7 0.1× 98 1.4× 23 658

Countries citing papers authored by Andreas Moritz

Since Specialization
Citations

This map shows the geographic impact of Andreas Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Moritz more than expected).

Fields of papers citing papers by Andreas Moritz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Moritz. The network helps show where Andreas Moritz may publish in the future.

Co-authorship network of co-authors of Andreas Moritz

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Moritz. A scholar is included among the top collaborators of Andreas Moritz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Moritz. Andreas Moritz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Krämer, Stefan, Andreas Moritz, Meike Hutt, et al.. (2023). An ultra-high-throughput screen for the evaluation of peptide HLA-Binder interactions. Scientific Reports. 13(1). 5290–5290. 4 indexed citations
2.
Moritz, Andreas, Annika Nelde, Tatjana Bilich, et al.. (2021). SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function. European Journal of Immunology. 51(11). 2651–2664. 6 indexed citations
3.
Moritz, Andreas, Claudia Wagner, Sebastian Bunk, et al.. (2019). High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules. Science Immunology. 4(37). 29 indexed citations
4.
Weiss, Douglas J., Oral A. Evanson, Andreas Moritz, Ming Qi Deng, & Mitchell S. Abrahamsen. (2002). Differential Responses of Bovine Macrophages toMycobacterium aviumsubsp.paratuberculosisandMycobacterium aviumsubsp.avium. Infection and Immunity. 70(10). 5556–5561. 97 indexed citations
5.
Moritz, Andreas, Kawe Goharkhay, Ulrich Schoop, et al.. (2000). Morphologic changes correlating to different sensitivities of Escherichia coli and Enterococcus faecalis to Nd:YAG laser irradiation through dentin. Lasers in Surgery and Medicine. 26(3). 250–250. 7 indexed citations
6.
Goharkhay, Kawe, et al.. (1999). Effects on oral soft tissue produced by a diode laser in vitro. Lasers in Surgery and Medicine. 25(5). 401–406. 26 indexed citations
7.
Moritz, Andreas, Ulrich Schoop, Kawe Goharkhay, & Wolfgang R. Sperr. (1998). The CO2 laser as an aid in direct pulp capping. Journal of Endodontics. 24(4). 248–251. 34 indexed citations
8.
Moritz, Andreas, et al.. (1998). Treatment of periodontal pockets with a diode laser. Lasers in Surgery and Medicine. 22(5). 302–311. 246 indexed citations
9.
Reeve, P., H. Bachmayer, E. Liehl, et al.. (1982). Studies in man with a cold‐recombinant live influenza b virus vaccine. Journal of Medical Virology. 9(1). 1–9. 14 indexed citations
10.
Moritz, Andreas, et al.. (1980). Studies with a Cold-Recombinant A/Victoria/3/7S (H3N2) Virus. II. Evaluation in Adult Volunteers. The Journal of Infectious Diseases. 142(6). 857–860. 34 indexed citations
11.
Kunz, Ch., H Hofmann, Andreas Moritz, H. Bachmayer, & E. Liehl. (1978). Eine neue Influenza Subunit Vakzine: Hämagglutinations-hemmende Antikörper ein Jahr nach der Impfung. Infection. 6(5). 217–220. 1 indexed citations
12.
Just, M, et al.. (1978). [Staff vaccination with a new subunit influenza vaccine].. PubMed. 108(2). 47–52. 1 indexed citations
13.
Just, M, et al.. (1978). A/New Jersey/76 influenza vaccine trial in seronegative schoolchildren: Comparison of a subunit vaccine with a whole-virus vaccine. Medical Microbiology and Immunology. 164(4). 277–284. 10 indexed citations
14.
Moritz, Andreas, et al.. (1978). Impfung von Klein- und Schulkindern mit einer Influenza Subunit Vakzine. Infection. 6(5). 221–227. 3 indexed citations
15.
Kunz, C, H Hofmann, H. Bachmayer, et al.. (1976). Eine neue Influenza-Subunit-Vakzine: Verträglichkeit und Antigenität im Vergleich zu herkömmlichen Spalt- und Ganzvirusvakzinen. Infection. 4(2). 73–79. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruchele Dias Nogueira Breakdown of academic impact, for papers by Clay A. Henry Breakdown of academic impact, for papers by Mathias Folwaczny Breakdown of academic impact, for papers by Claudia Ota‐Tsuzuki Breakdown of academic impact, for papers by Ruoqiong Chen Breakdown of academic impact, for papers by Preethi Balan Breakdown of academic impact, for papers by V. T. Beena Breakdown of academic impact, for papers by C. George Breakdown of academic impact, for papers by Kåre Tolo Breakdown of academic impact, for papers by R. Dei
Rankless by CCL
2026